Literature DB >> 6337600

Effects of dazoxiben, an inhibitor of thromboxane synthetase, on forearm vasoconstriction in response to cold stimulation, and on human blood vessel prostacyclin production.

A J Cowley, E W Jones, S P Hanley.   

Abstract

1 In healthy male volunteers dazoxiben (UK 37248), an inhibitor of thromboxane synthetase, abolished the arterial and venous vasoconstriction produced in the forearm by cold stimulation. 2 Aspirin alone had no effect on this vasoconstriction but negated the effect of dazoxiben. 3 In vitro dazoxiben increased the production of prostacyclin by human arteries and veins. 4 By reducing the synthesis of thromboxane A2, a potent vasoconstrictor, and by increasing the synthesis of prostacyclin, a potent vasodilator, dazoxiben may have a therapeutic role in conditions associated with abnormal vasoconstriction.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6337600      PMCID: PMC1427702          DOI: 10.1111/j.1365-2125.1983.tb02118.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  11 in total

1.  Effect on forearm arteries and veins of attenuation of the cardiac response to leg exercise.

Authors:  B F Robinson; A G Wilson
Journal:  Clin Sci       Date:  1968-08       Impact factor: 6.124

2.  Aspirin selectively inhibits prostaglandin production in human platelets.

Authors:  J B Smith; A L Willis
Journal:  Nat New Biol       Date:  1971-06-23

3.  Administration to man of UK-37,248-01, a selective inhibitor of thromboxane synthetase.

Authors:  H M Tyler; C A Saxton; M J Parry
Journal:  Lancet       Date:  1981-03-21       Impact factor: 79.321

4.  Prostacyclin and thromboxane A2 formation in response to adrenergic stimulation in humans: a mechanism for local control of vascular response to sympathetic activation?

Authors:  G G Serneri; G Masotti; G F Gensini; L Poggesi; R Abbate; M Mannelli
Journal:  Cardiovasc Res       Date:  1981-05       Impact factor: 10.787

5.  Differential inhibition by low-dose aspirin of human venous prostacyclin synthesis and platelet thromboxane synthesis.

Authors:  S P Hanley; J Bevan; S R Cockbill; S Heptinstall
Journal:  Lancet       Date:  1981-05-02       Impact factor: 79.321

6.  Thromboxane synthetase inhibition as antithrombotic strategy.

Authors:  J Vermylen; G Defreyn; L O Carreras; S J Machin; J Van Schaeren; M Verstraete
Journal:  Lancet       Date:  1981-05-16       Impact factor: 79.321

7.  Platelet and blood vessel arachidonate metabolism and interactions.

Authors:  P Needleman; A Wyche; A Raz
Journal:  J Clin Invest       Date:  1979-02       Impact factor: 14.808

8.  Cardiovascular responses to lower body negative pressure in normal subjects and in patients with diabetes mellitus.

Authors:  T Bennett; D J Hosking; J R Hampton
Journal:  Cardiovasc Res       Date:  1979-01       Impact factor: 10.787

9.  Comparative assessment of stimuli that release neuronal and adrenomedullary catecholamines in man.

Authors:  D Robertson; G A Johnson; R M Robertson; A S Nies; D G Shand; J A Oates
Journal:  Circulation       Date:  1979-04       Impact factor: 29.690

10.  Coronary vasoconstrictor effect of indomethacin in patients with coronary-artery disease.

Authors:  P L Friedman; E J Brown; S Gunther; R W Alexander; W H Barry; G H Mudge; W Grossman
Journal:  N Engl J Med       Date:  1981-11-12       Impact factor: 91.245

View more
  1 in total

1.  The effects of dazoxiben, an inhibitor of thromboxane synthetase, on cold-induced forearm vasoconstriction and platelet behaviour in different individuals.

Authors:  A J Cowley; E W Jones; A J Carter; S P Hanley; S Heptinstall
Journal:  Br J Clin Pharmacol       Date:  1985-01       Impact factor: 4.335

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.